Lindapt Joosten News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Frail patients with atrial fibrillation who were switched to a newer NOAC agent had more bleeding than those left on older vitamin K antagonists, without any benefit in terms of thromboembolic events.

Van gelderLindapt joostenIsabellec van gelderRenateb schnabelUniversity medical centre groningenUniversity heart vascular center hamburgEuropean society of cardiology congressJulius centerEuropean heart rhythm associationHealth sciencesInternational normalizedBoehringer ingelheimPrimary careEuropean societyCardiology congressUniversity heart